test

Nathalie Auber

@Sofinnova Investments, Inc.

Latest period2024 - Q3ReportedManaged Assets$1.26BTotal holdings58
Assets growth rate-34.51%Assets growth rate (2-Q avg)-13.66%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sofinnova Investments, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 58 positions.

Assets under management

The assets under management (AUM) of Sofinnova Investments, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.26B in assets, with a quarterly growth rate of -34.51% and a 2-quarter average growth rate of -13.66%. The portfolio is managed by Nathalie Auber, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NTRANatera Inc
Recent Activity
15.62%
$196.808M
1.55M shares@ $126.95 avg price
VERAVera Therapeutics Inc
Recent Activity
9.81%
$123.494M
2.794M shares@ $44.2 avg price
NVONovo-nordisk A S
Recent Activity
Increased 11.83%
6.87%
$86.484M
726,329 shares@ $119.07 avg price
AZNAstrazeneca Plc
Recent Activity
Increased 1%
5.01%
$63.061M
809,406 shares@ $77.91 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Increased 51.93%
4.4%
$55.423M
1.749M shares@ $31.68 avg price
ELANElanco Animal Health Inc
Recent Activity
Increased 22.85%
4.11%
$51.689M
3.519M shares@ $14.7 avg price
BIOABioage Labs Inc
Recent Activity
New Position
3.81%
$47.942M
2.305M shares@ $20.81 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Increased 70.71%
3.78%
$47.589M↓ Put
529,527 shares@ $89.87 avg price
INCYIncyte Corp
Recent Activity
New Position
3.75%
$47.207M
714,176 shares@ $66.11 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
Increased 59.89%
3.56%
$44.752M
886,344 shares@ $50.5 avg price